Philip Beer's Location
Greater Cambridge Area, United Kingdom, United Kingdom
About Philip Beer
Physician scientist and cancer biologist with expertise in early phase drug development, translational medicine and biomarker discovery. Follow me on Twitter on a thread dedicated to oncology drugs and biomarkers: @cancer_evolve
Philip Beer Work Experience Details
-
Chief Scientific OfficerStep Pharma Dec 2022 - PresentSaint-Genis-Pouilly, Auvergne-Rhône-Alpes, Fr -
Vice President, Head Of Research And Translational MedicineStep Pharma Jul 2021 - Nov 2022Saint-Genis-Pouilly, Auvergne-Rhône-Alpes, FrStep Pharma is developing novel therapeutics that inhibit the enzyme CTP Synthase 1 (CTPS1). Our most advanced molecule, STP938, is in phase 1 development for patients with relapsed/refractory B or T cell lymphoma (NCT05463263).
-
Honorary Professor, Translational MedicineHull York Medical School (Hyms) Jun 2020 - PresentYork, GbUndergraduate teaching at the Medical School; supporting academic research as an honorary member of the York Biomedical Research Institute, University of York. -
Chair, Genomics Working GroupBritish In Vitro Diagnostics Association (Bivda) Apr 2021 - PresentLondon, Gb -
Clinical Cancer GenomicsNhs Apr 2020 - PresentGbSupporting genomic profiling and biomarker-driven clinical trials. -
Clinical Cancer GenomicsNhs Sep 2018 - Mar 2020GbDelivery of the 100,000 genomes project cancer samples (East of England & the North East).
-
Consultant HaematopathologistNhs Jun 2017 - Sep 2018GbCellular and molecular pathology.
-
Founder And ChairGabriel Precision Oncology Sep 2020 - PresentGlasgow, GbMaking precision oncology a reality for those living with cancer. -
Research CollaboratorMayo Clinic Apr 2018 - PresentRochester, Minnesota, UsCancer biology and model systems with Raj Kannan. -
Visiting ScientistWellcome Sanger Institute Jun 2014 - PresentHinxton, Cambridgeshire, GbCancer genomics and clinical outcome prediction. -
Clinical Cancer GenomicsIcgc Argo May 2017 - PresentBearsden, Scotland, GbInternational Cancer Genome Consortium's next generation project- Accelerating Research in Genomic Oncology. -
Therapeutic Board MemberPrecision-Panc Nov 2016 - PresentGlasgow, GbUK-wide clinical trials network in pancreatic cancer. -
Head Of Research And Translational MedicineKarus Therapeutics Limited Apr 2020 - Jun 2021Therapeutic development in oncology and other indications.
-
Head Of Translational MedicineKarus Therapeutics Limited Jul 2017 - Apr 2020Preclinical development | Clinical trial pharmacodynamics | Exploratory & translational studies.
-
Head Of Genomic StrategyGlasgow Precision Oncology Laboratory Oct 2016 - Jun 2021Driving oncology drug discovery through translational reserarch and biomarker discover. -
Uk Medical DirectorOncodna, The Cancer Theranostic Company Jan 2018 - Mar 2021Gosselies, Walloon Region, BeGenomic data interpretation and clinical support. -
Head Of Translational MedicineCambridge Cancer Genomics Jul 2019 - Sep 2020Cambridge, Cambridgeshire, GbUnlocking clinical utility of AI-led genomic analysis and interpretation. -
Medical AdvisorCure Forward Nov 2016 - Jun 2017Innovative patient-centred approach to increase & expedite trial enrolment for individuals with cancer. A project that was ahead of its time, and has now ceased operations due to financial difficulties. Personal contributions included patient profile construction & clinical trial selection (>200 individuals), actionability analysis of molecular profiles (somatic & germline) and mapping of clinical trial landscapes.
-
Director Of Medical Genomics14M Genomics Ltd Feb 2014 - Feb 2016GbLeadership of medical/scientific team at erstwhile cancer genomics start-up, working in partnership with the Sanger Institute and collaborators across the UK and Europe. -
Post-Doctoral FellowBc Cancer Agency Apr 2010 - Mar 2014Vancouver, British Columbia, CaResearch with Dr Connie Eaves at the Terry Fox Laboratory focussed on the generation of improved in vitro and in vivo models of leukaemia through the genetic manipulation of normal and pre-leukaemic human blood cells. -
Clinical LecturerCambridge University Hospitals Nhs Foundation Trust Jan 2009 - Mar 2010Cambridge, GbTranslational research and patient care in the Department of Haematology at Addenbrooke's Hospital. -
Clinical Research FellowUniversity Of Cambridge Sep 2005 - Dec 2008Cambridge, England, GbResearch with Prof. Tony Green focussed on the study of genotype-phenotype correlations in human leukaemia. -
Specialist RegistrarImperial College Healthcare Nhs Trust Jan 2001 - Aug 2005London, GbSpecialist training in clinical and laboratory haematology at Hammersmith, Charing Cross & St Mary’s Hospitals.
Philip Beer Education Details
-
University Of CambridgePhd -
University Of NottinghamBs
-
Royal College Of PathologistsFrcpath
-
Royal College Of PhysiciansMrcp
Frequently Asked Questions about Philip Beer
What company does Philip Beer work for?
Philip Beer works for Step Pharma
What is Philip Beer's role at the current company?
Philip Beer's current role is CSO at Step Pharma.
What schools did Philip Beer attend?
Philip Beer attended University Of Cambridge, University Of Nottingham, Royal College Of Pathologists, Royal College Of Physicians.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial